Furthermore, in a randomized trial, statin therapy significantly reduced the incidence of major cardiovascular events among people without hyperlipidemia but with elevated CRP level (Ridker et al., 2008), which further supported the anti-inflammatory effect of statin. Here, CRP is linked to hyperlipidemia.